Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

3(42.9%)

7Total

Phase 4(4)

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT02928679Phase 4Completed

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

Role: lead

NCT02931383Phase 4Completed

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

Role: lead

NCT02905864Phase 4Completed

Liraglutide 3 mg for Knee Osteoarthritis

Role: lead

NCT02928614Phase 4Completed

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance

Role: lead

NCT02954627Completed

Ultrasound Assessment of the Carotid Intimal Medial Thickness in Obese Subjects; Weight Loss

Role: lead

NCT02931370Completed

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

Role: lead

NCT02928471Completed

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss

Role: lead

NCT03208881Unknown

Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness

Role: lead

NCT02931344Not ApplicableUnknown

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Loss

Role: lead

NCT02317939Not ApplicableCompleted

Home Monitoring of Patients With Rheumatoid Arthritis - an eHealth Development Study

Role: lead

NCT02818478Not ApplicableCompleted

Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis

Role: lead

All 11 trials loaded